CONCORD MED SVCS HLDGS LTD SPON ADR NEW - ADR (CCM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / ADR
Symbol
CCM on NYSE
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
0
Total reported value
$0
Share change
-440
Value change
-$2,702
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of CONCORD MED SVCS HLDGS LTD SPON ADR NEW - ADR (CCM).

Institutional Holders of CONCORD MED SVCS HLDGS LTD SPON ADR NEW - ADR (CCM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$2,702 0
2025 Q3 440 $2,702 +$1,001 $6.14 1
2025 Q2 277 $1,587 +$1,587 $5.73 1
2024 Q3 0 $0 -$77,152 0
2024 Q2 81,214 $77,152 +$33,290 $0.95 4
2024 Q1 46,181 $26,030 -$4,323 $0.56 3
2023 Q4 53,600 $59,269 -$13,501 $1.10 4
2023 Q3 65,802 $84,298 -$16,139 $1.28 4
2023 Q2 78,399 $107,726 -$11,277 $1.38 3
2023 Q1 86,643 $108,303 -$23,826 $1.25 3
2022 Q4 105,641 $173,168 -$14,988 $1.64 4
2022 Q3 114,785 $212,000 -$31,218 $1.84 2
2022 Q2 131,685 $247,000 -$25,582 $1.85 2
2022 Q1 145,332 $249,000 -$17,892 $1.77 2
2021 Q4 155,921 $312,000 -$48,811 $2.22 2
2021 Q3 180,464 $558,000 -$187,797 $3.44 2
2021 Q2 242,855 $697,000 -$327,944 $2.87 5
2021 Q1 357,182 $1,372,000 +$89,271 $3.84 7
2020 Q4 333,949 $915,000 -$107,054 $2.74 2
2020 Q3 381,507 $753,000 +$26,767 $1.97 4
2020 Q2 367,449 $608,000 -$8,539 $1.65 3
2020 Q1 372,319 $666,000 +$1,856 $1.76 4
2019 Q4 371,314 $991,000 -$24,196 $2.67 4
2019 Q3 381,733 $921,000 -$831,193 $2.40 5
2019 Q2 752,694 $1,685,000 -$68,716 $2.24 9
2019 Q1 777,258 $2,183,000 +$42,013 $2.80 9
2018 Q4 763,720 $2,719,000 +$14,234 $3.56 8
2018 Q3 759,596 $2,696,000 +$112,076 $3.55 8
2018 Q2 728,178 $3,023,000 -$69,237 $4.15 6
2018 Q1 750,542 $2,147,000 -$82,834 $2.86 8
2017 Q4 774,639 $2,579,000 -$15,911,261 $3.33 7
2017 Q3 5,311,192 $18,644,000 -$534,592 $3.51 12
2017 Q2 5,470,671 $20,516,000 -$160,473 $3.75 16
2017 Q1 5,513,740 $26,022,000 +$84,279 $4.72 17
2016 Q4 5,495,892 $25,248,000 -$244,661 $4.60 17
2016 Q3 5,556,830 $22,103,000 -$231,934 $3.98 14
2016 Q2 5,617,528 $21,627,000 -$1,702,046 $3.85 16
2016 Q1 6,026,436 $29,650,000 -$228,720 $4.92 19
2015 Q4 6,071,784 $29,389,000 -$1,885,410 $4.84 22
2015 Q3 6,470,954 $30,093,000 +$377,901 $4.65 24
2015 Q2 6,265,565 $44,172,000 +$1,148,645 $7.05 22
2015 Q1 6,069,524 $35,631,000 -$567,040 $5.87 21
2014 Q4 6,244,990 $40,122,302 -$119,255 $6.41 20
2014 Q3 6,261,693 $45,080,000 -$630,383 $7.20 25
2014 Q2 6,335,339 $50,796,266 +$950,032 $8.03 24
2014 Q1 6,222,479 $47,001,000 -$2,025,287 $7.55 24